Similarly, IGF-1 administration improved liver function (increased albumin, total protein, and coagulation factor levels) and reduced oxidative liver damage and fibrosis in rat models with CCl4-induced cirrhosis (26). This evidence concerns the gene IGF1 and fibrosis.